Study of the Safety, Tolerability and Pharmacokinetics of TIMP-GLIA in Subjects With Celiac Disease
Clinical trial NCT03486990 · COMPLETED
Trial details
- NCT number
- NCT03486990
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-23
- Primary completion
- 2019-05-24
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.